By Molika Ashford

A proteomic study by researchers at the University of Missouri and Harry S. Truman Memorial Veterans' Hospital has identified signaling networks that are potentially involved in the metastasis of breast cancer to the brain, suggesting the need for new treatment paradigms.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.